First Time Loading...
Y

Yifan Pharmaceutical Co Ltd
SZSE:002019

Watchlist Manager
Yifan Pharmaceutical Co Ltd
SZSE:002019
Watchlist
Price: 13.24 CNY 3.36% Market Closed
Updated: May 1, 2024

Yifan Pharmaceutical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Yifan Pharmaceutical Co Ltd
Operating Income Peer Comparison

Comparables:
C
1093
H
3692
600436
600276
000538

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Y
Yifan Pharmaceutical Co Ltd
SZSE:002019
Operating Income
¥135.8m
CAGR 3-Years
-53%
CAGR 5-Years
-36%
CAGR 10-Years
35%
C
CSPC Pharmaceutical Group Ltd
HKEX:1093
Operating Income
¥7.7B
CAGR 3-Years
12%
CAGR 5-Years
16%
CAGR 10-Years
23%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Operating Income
¥3.7B
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Operating Income
¥3.3B
CAGR 3-Years
22%
CAGR 5-Years
22%
CAGR 10-Years
21%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Operating Income
¥3.6B
CAGR 3-Years
-17%
CAGR 5-Years
-3%
CAGR 10-Years
10%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Operating Income
¥3.7B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
6%

See Also

What is Yifan Pharmaceutical Co Ltd's Operating Income?
Operating Income
135.8m CNY

Based on the financial report for Sep 30, 2023, Yifan Pharmaceutical Co Ltd's Operating Income amounts to 135.8m CNY.

What is Yifan Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
35%

Over the last year, the Operating Income growth was -22%. The average annual Operating Income growth rates for Yifan Pharmaceutical Co Ltd have been -53% over the past three years , -36% over the past five years , and 35% over the past ten years .